Advair Diskus approved for younger asthma patients also

Advair Diskus – a combination of fluticasone propionate and salmeterol inhalation powder – is approved by FDA for the twice-daily treatment of asthma in patients aged four years and older and maintenance treatment of airflow obstruction and reducing exacerbations in patients with chronic obstructive pulmonary disease (COPD). Mylan obtained approval to market its generic inhaler … Read more

Limit screen-based recreational media at home

Screen time from computers, phones, tablet computers, video games, TV and other screen-based devices is associated with an increased amount of sedentary behavior in children and teens, according to a new scientific statement released by the American Heart Association and published in its journal Circulation. Sedentary behaviors include sitting, reclining or laying down while awake … Read more

Probiotic use linked to brain fogginess & bloating

Probiotic use can result in a significant accumulation of bacteria in the small intestine that can result in disorienting brain fogginess as well as rapid, significant belly bloating, investigators report. In a published study of 30 patients, the 22 who reported problems like confusion and difficulty concentrating, in addition to their gas and bloating, were … Read more

Azedra injection – first treatment approved for rare adrenal tumors

The U.S. Food and Drug Administration approved Azedra (iobenguane I 131) injection for intravenous use for the treatment of adults and adolescents age 12 and older with rare tumors of the adrenal gland (pheochromocytoma or paraganglioma) that cannot be surgically removed (unresectable), have spread beyond the original tumor site and require systemic anticancer therapy. This … Read more

Do NOT follow this link or you will be banned from the site!